Risks of Living Donor Liver Transplantation Using Small-For-Size Grafts

被引:9
|
作者
Miyagi, Shigehito [1 ]
Shono, Yoshihiro [1 ]
Tokodai, Kazuaki [1 ]
Nakanishi, Wataru [1 ]
Nishimura, Ryuichi [1 ]
Fujio, Atsushi [1 ]
Sasaki, Kengo [1 ]
Miyazaki, Yuki [1 ]
Kakizaki, Yuta [1 ]
Sasajima, Hideaki [1 ]
Kamei, Takashi [1 ]
Unno, Michiaki [1 ]
机构
[1] Tohoku Univ, Dept Surg, Grad Sch Med, Sendai, Miyagi, Japan
关键词
SPLENECTOMY;
D O I
10.1016/j.transproceed.2020.01.136
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. In living donor liver transplantation (LDLT), a graft-to-recipient weight ratio (GRWR) of under 0.8 is recognized as the critical graft size. Our aim was to compare the survival rates of recipients with small-for-size grafts (SFSG: GRWR <0.8), normal-sized grafts (NSG), and large-for-size grafts (LFSG: GRWR >= 3.5) and to investigate the mortality risk with SFSG. Methods. Between 1991 and April 2019, we performed 188 LDLT surgeries. Recently, we added splenectomy when portal vein pressure is high (>17 mm Hg) to interrupt the splenic bloodstream. We divided all LDLT cases retrospectively into 3 groups: an SFSG group (n = 22), NSG group (n = 154), and LFSG group (n = 12). We investigated the survival rates in these groups. Furthermore, we divided the SFSG group into 2 subgroups: an SFSG with splenectomy (SFSGthornS) group (n = 7) and an SFSG without splenectomy group. We investigated the occurrence rates of lethal complications such as portal vein thrombosis, hepatic artery thrombosis, and hepatic vein thrombosis. Results. The 5-year survival rate in the SFSG group was significantly lower (52.8%) than in the other groups (NSG: 84.5%; LFSG: 83.3%), but that of the SFSGthornS group was similar (80.0%) to that of other groups. There was no difference in the occurrence of postoperative complications such as portal vein thrombosis, hepatic artery thrombosis, or hepatic vein thrombosis between the SFSGthornS group and other groups. Conclusions. Graft survival of LDLT using SFSGthornS was as good as that of normal-sized grafts. Reducing portal vein pressure was important for SFSG.
引用
收藏
页码:1825 / 1828
页数:4
相关论文
共 50 条
  • [41] A systematic review of small for size syndrome after major hepatectomy and liver transplantation
    Riddiough, Georgina E.
    Christophi, Christopher
    Jones, Robert M.
    Muralidharan, Vijayaragavan
    Perini, Marcos V.
    HPB, 2020, 22 (04) : 487 - 496
  • [42] Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts
    Hwang, Jeong Kye
    Kim, Sang Il
    Choi, Bum Soon
    Yang, Cheol Woo
    Kim, Yong Soo
    Moon, In Sung
    Kim, Ji Il
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2011, 81 (01): : 10 - 18
  • [43] Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation
    Elshawy, Mohamed
    Toshima, Takeo
    Asayama, Yoshiki
    Kubo, Yuichiro
    Ikeda, Shinichiro
    Ikegami, Toru
    Arakaki, Shingo
    Yoshizumi, Tomoharu
    Mori, Masaki
    SURGICAL CASE REPORTS, 2020, 6 (01)
  • [44] Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation
    Kishi, Y
    Sugawara, Y
    Akamatsu, N
    Kaneko, J
    Tamura, S
    Kokudo, N
    Makuuchi, M
    CLINICAL TRANSPLANTATION, 2005, 19 (06) : 769 - 772
  • [45] Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation
    Sato, Y
    Yamamoto, S
    Oya, H
    Nakatsuka, H
    Tsukahara, A
    Kobayashi, T
    Watanabe, T
    Hatakeyama, K
    HEPATO-GASTROENTEROLOGY, 2002, 49 (48) : 1652 - 1655
  • [46] The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation: The experience of a single center
    Okada, Noriki
    Sanada, Yukihiro
    Hirata, Yuta
    Yamada, Naoya
    Wakiya, Taiichi
    Ihara, Yoshiyuki
    Urahashi, Taizen
    Miki, Atsushi
    Kaneda, Yuji
    Sasanuma, Hideki
    Fujiwara, Takehito
    Sakuma, Yasunaru
    Shimizu, Atsushi
    Hyodo, Masanobu
    Yasuda, Yoshikazu
    Mizuta, Koichi
    PEDIATRIC TRANSPLANTATION, 2015, 19 (03) : 279 - 286
  • [47] Liver Graft-to-Spleen Volume Ratio as a Useful Predictive Factor of the Outcomes in Living Donor Liver Transplantation: A Retrospective Study
    Xiao, Fei
    Wei, Lin
    Qu, Wei
    Zeng, Zhi-Gui
    Sun, Li-Ying
    Liu, Ying
    Zhang, Hai-Ming
    Tan, Yu-Le
    Wang, Jun
    Zhu, Zhi-Jun
    FRONTIERS IN SURGERY, 2022, 9
  • [48] Splenic devascularization can replace splenectomy during adult living donor liver transplantation - a historical cohort study
    Moon, Deok-Bog
    Lee, Sung-Gyu
    Hwang, Shin
    Ahn, Chul-Soo
    Kim, Ki-Hun
    Ha, Tae-Yong
    Song, Gi-Won
    Jung, Dong-Hwan
    Park, Gil-Chun
    Yoon, Young-In
    Cho, Hwui-Dong
    Kwon, Jae-Hyun
    Jung, Yong-Kyu
    Ha, Su-Min
    TRANSPLANT INTERNATIONAL, 2019, 32 (05) : 535 - 545
  • [49] Splenic Artery Embolization for Splenic Artery Steal Syndrome After Living Donor Liver Transplantation: A Case Report
    Jiang, Jiayun
    Ji, Yujun
    Liang, Yong
    Ou, Yanjiao
    Zhang, Leida
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (10) : 2772 - 2778
  • [50] CD4 T lymphocyte counts in patients undergoing splenectomy during living donor liver transplantation
    Natsuda, Koji
    Eguchi, Susumu
    Takatsuki, Mistuhisa
    Soyama, Akihiko
    Hidaka, Masaaki
    Hara, Takanobu
    Kugiyama, Tota
    Baimakhanov, Zhassulan
    Ono, Shinichiro
    Kitasato, Amane
    Fujita, Fumihiko
    Kanetaka, Kengo
    Kuroki, Tamotsu
    TRANSPLANT IMMUNOLOGY, 2016, 34 : 50 - 53